<DOC>
	<DOCNO>NCT01448642</DOCNO>
	<brief_summary>The purpose study determine whether load dose atorvastatin percutaneous intervention procedure acute coronary syndrome effective reduce major cardiovascular event ( MACE ) .</brief_summary>
	<brief_title>Statins Evaluation Coronary Procedures Revascularization Trial</brief_title>
	<detailed_description>Background : Strategies reduce complication acute coronary syndrome treatment largely study . Due pleiotropic effect statins consider important tool atherosclerotic plaque stability . Although , usage statin percutaneous coronary intervention acute coronary syndrome patient , yet demonstrate . Objectives : Evaluate load dose atorvastatin ( 80mg ) percutaneous coronary intervention acute coronary syndrome patient , follow reload dose 24 hour , able reduce major cardiovascular event ( MACE ) ; include combine outcomes all-cause mortality , nonfatal acute myocardial infarction , stroke revascularization either percutaneous coronary intervention coronary-artery bypass graft 30 day . Methods : Multicentric randomise control clinical trial , allocation concealment intention treat analysis . Competitive recruitment involve 4,192 patient . Acute coronary syndrome patient intend undergo percutaneous coronary intervention without stent placement randomize 1:1 receive either atorvastatin 80mg placebo coronary procedure also reload dosage 24 hour angioplasty . All patient collect blood sample determine CKMB level pre post procedure ( 6 12h 18 24 hour ) . After 30 day , person interview perform blood sample collect order dosage AST , ALT , CPK , cholesterol level . Telephonic interview do 6 12 month access occurrence cardiovascular event .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Acute coronary syndrome patient intend undergo percutaneous coronary intervention . Younger 18 year Presence contraindication statin ( Pregnant woman , breastfeed woman statin hypersensibility ) Advanced hepatic disease Use statins maximum dosage last 24 hour load dose study drug Use fibrate last 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>